drugset / Trial / NCT02661594

Thorough QT Study of Intravenous Amisulpride

NCT02661594

Phase 1 Completed 40 enrolled Acacia Pharma Ltd
RandomizedCrossoverQuadruple-blindOther

Summary

Randomised, single-dose, crossover, placebo-controlled study to see if intravenous amisulpride has any effect on the heart rhythm, in particular the QT interval, in healthy adult volunteers.

Timeline

Start
2013-11
Primary completion
2014-03
Completion
2014-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Amisulpride Small molecule 5 mg Intravenous
Subject Amisulpride Small molecule 40 mg Intravenous
Subject Moxifloxacin Small molecule 400 mg

Indications

No indication recorded.